Strategically Mapped for Global Research

A Global Partner in Clinical Development

Medpace has the global reach to conduct biopharmaceutical and medical device studies around the world. With coverage across six continents, Medpace has the global expertise and experience to proactively plan and execute trials of all sizes. Our medical, operational, and regulatory specialists have country-specific expertise which allows them to acquire a deeper understanding of the importance of local language, culture, and processes. By being embedded in the culture, we can create better relationships with investigators, deliver faster enrollment timelines, and obtain access to the country specific patient populations.

Local Expertise | Global Experience

Global reach for clinical research
Projects are facilitated through regional offices located throughout Europe, North America, Asia, Australia, South Africa, and Latin America with staff and offices continually added throughout the world. Countries in green represent where we have conducted studies. Click here for a list of office locations.

North America

World Headquarters – A One-of-a-Kind Clinical Research Campus

Medpace Clinical research campus
Global headquarters in Cincinnati, OH – part of the Clinical Research Campus

Medpace is the only global CRO with a fully integrated Clinical Research Campus. With the CRO headquartered beside critical supporting services, we are able to build greater collaboration, efficiency, and streamlined execution – which drives better results. Also located on the research campus are these wholly-owned subsidiaries:

Additional US Offices

  • Dallas, TX is home to a clinical operations office where staff are located in the hub of an active and growing life science cluster
  • Denver, CO is home to our newest US office, where we have both clinical and corporate resources supporting multiple business functions


With well-developed medical and healthcare systems, and an experienced and mature site infrastructure for conducting clinical trials, the European Union (EU), Central and Eastern Europe (CEE), and Israel combine to be an advantageous landscape for conducting clinical research.

Regional Medpace highlights include:

  • Fully-established and mature operations since 2005
  • Extensive site database with corresponding performance metrics enables quick identification of high quality sites facilitating access to patients
  • In-house regulatory expertise that covers the full array of medicinal products & routes of administration, from  NCEs to biologicals & ATMPs
  • Presence in the region includes the support by local offices, global central laboratory (Belgium), and imaging capabilities (France)


Asia-Pacific countries offer access to large patient populations for local clinical studies, as well as large global studies.

Regional Medpace highlights include:

  • Well-established with operations since 2004
  • Well-profiled networks of sites across multiple therapeutic areas
  • Experienced staff with country-specific expertise and site relationships
  • Central laboratories in Singapore and Shanghai
  • Specialized experience in China supporting sponsors with scientific and regulatory guidance for early phase clinical development

Latin America

Clinical trials have been conducted in Latin America for over 25 years and is becoming an increasingly important region for conducting research.

Regional Medpace highlights include:

  • Operational excellence beginning in 2006
  • Offices in Argentina, Brazil, Mexico, and operational partners in Peru, Colombia, and Central America
  • Access to qualified, reliable, committed and experienced healthcare professionals with culturally stronger patient-physician relationships that facilitates enrollment and adherence

Learn More About Latin America Supporting Drug Development

Latin America



Global clinical trials have been conducted in South Africa for almost 40 years.

Regional Medpace highlights include:

  • Medpace opened an office in Johannesburg, South Africa in 2006, providing the ideal base to manage and monitor studies in other central and southern African countries
  • Experience conducting multiple studies in a variety of indications
  • Strong site relationships
  • Knowledge of the various regulatory requirements of South African countries

Learn More About Africa Supporting Drug Development